US Doctors Push Flu and Covid Boosters as Trump Guidance Falters
- AAP, AAFP, ACOG and IDSA release joint guidance on 2 Sept 2026
- FDA approves updated 2026‑2027 Covid‑19 vaccine on 28 Aug 2026
- Flu shots start distribution in 45 states this week
- RSV hospitalisations up 18% in children under 5 since last winter
- Trump administration reverses its earlier stance on vaccine timing
The American Academy of Pediatrics (AAP) issued a stark call on Wednesday, 2 Sept 2026, for every child aged six months to 18 years to receive the seasonal flu vaccine before the end of October.
Dr Sarah Mitchell, president of the AAP, said the agency's data show a 27 % rise in paediatric influenza‑related hospital admissions compared with the same period in 2023.
"We cannot afford another wave that overwhelms paediatric wards," Mitchell said.
The AAP's guidance follows the Food and Drug Administration's (FDA) clearance of this year's quadrivalent flu formulation on 22 Aug 2026.
- Flu vaccine available in 45 states, covering 96 % of the US population • Target uptake 70 % for children, 60 % for adults • School‑based clinics to start on 5 Oct 2026
Officials said the rollout will prioritise schools in the Midwest and South, where last season's flu activity peaked.
The AAP also flagged that unvaccinated children are twice as likely to contract respiratory syncytial virus (RSV) this winter, a point that will be expanded in a later section.
Parents who hesitate are urged to speak with their child's primary‑care physician, as the AAP stresses that the vaccine is safe for children with asthma, diabetes or mild immune deficiencies.
The organisation will distribute a printable FAQ to over 150 000 paediatric clinics by the end of the month.
Family Physicians Group Recommends Updated COVID‑19 Booster for Adults Over 65
The American Academy of Family Physicians (AAFP) released its own set of recommendations on the same day, urging adults aged 65 and over to receive the newly authorised COVID‑19 booster within the next four weeks.
Dr James O'Leary, senior fellow at the AAFP, told reporters that the updated vaccine targets the XBB.1.5 sub‑variant that accounted for 42 % of US cases in August.
"A single dose restores protection to 85 % against severe disease, according to the latest CDC data," O'Leary said.
The CDC's interim report, cited by the AAFP, shows that hospitalisations among unboosted seniors fell by 31 % after the booster rollout began in early September.
- Updated booster contains 15 µg of mRNA, half the dose of the original 2021 formulation • Distribution begins 1 Sept 2026 at pharmacies, community health centres and mobile units • Cost covered by Medicare and most private insurers
Experts noted that the booster's half‑dose design reduces side‑effects while maintaining efficacy, a factor that may persuade hesitant older adults.
Officials said the AAFP will partner with the National Council on Aging to run a tele‑health outreach campaign aimed at rural seniors in the Appalachian region.
The guidance also advises caregivers to coordinate flu and COVID shots on the same day, a practice supported by recent studies showing no increase in adverse events when administered together.
Obstetricians and Gynecologists Stress Vaccination for Expectant Mothers
The American College of Obstetricians and Gynecologists (ACOG) added a pregnancy‑focused layer to the joint guidance, recommending that all pregnant people receive both the flu shot and the updated COVID‑19 booster before 32 weeks gestation.
Dr Priya Patel, obstetrics specialist and ACOG spokesperson, explained that maternal vaccination cuts infant hospitalisation risk by 45 % for flu and 38 % for Covid‑19 in the first six months of life.
"The antibodies cross the placenta, offering newborns a shield during their most vulnerable weeks," Patel said.
Sources confirmed that ACOG will distribute vaccine kits to 2 200 obstetric clinics across the country, with a special focus on the Gulf Coast where last year's flu‑related infant deaths were highest.
- Flu vaccine safe in any trimester • COVID booster safe after the first trimester • Both vaccines can be given at the same visit
The guidance also addresses concerns about vaccine timing around the flu season, noting that a flu shot given as early as July still provides robust protection through March.
Officials said the ACOG will host a series of webinars for midwives and doulas to ensure consistent messaging at the point of care.
Infectious Diseases Society Highlights Rising RSV Threat in Children
The Infectious Diseases Society of America (IDSA) warned that RSV, long‑ignored outside of hospital intensive care units, is set to surge alongside flu and Covid this winter.
Dr Elena García, IDSA's epidemiology lead, cited CDC surveillance indicating an 18 % jump in RSV admissions among children under five since the 2024‑25 season.
"We are seeing RSV earlier, often in October, and it is hitting children who have not received any vaccine this year," García said.
The IDSA's recommendation is clear: vaccinate against flu and Covid now, and be prepared for the newly approved monoclonal antibody therapy for high‑risk infants, which the FDA authorised on 30 Aug 2026.
- RSV hospitalisations up 18 % in children <5 • Monoclonal antibody costs $1 200 per dose, covered by Medicaid in 34 states • Early‑season RSV testing to be offered at paediatric urgent‑care centres
Officials said the society will launch a public‑health alert in partnership with the CDC's Flu Season Preparedness Programme, targeting day‑care centres in the Northeast where RSV outbreaks have historically been most severe.
FDA Greenlights Updated COVID‑19 Vaccine, Distribution Begins
The FDA's approval on 28 Aug 2026 of the updated COVID‑19 vaccine, branded as CoviGuard‑2026, marks the first major regulatory action of the new administration.
The vaccine, developed by Moderna and Pfizer‑BioNTech, contains a modified spike protein that matches the XBB.1.5 lineage.
According to FDA officials, Phase III trials involving 32 000 participants showed a 92 % efficacy against symptomatic infection and a 97 % efficacy against hospitalisation.
- 15 µg mRNA per dose, half the original amount • Storage at 2‑8 °C for up to 30 days • First shipments arrived at 1 200 pharmacies on 30 Aug 2026
The rollout is being coordinated through the federal Vaccines for Children programme and the Department of Veterans Affairs, ensuring that both civilian and veteran populations receive doses simultaneously.
Experts noted that the half‑dose format may alleviate the supply bottleneck that plagued the 2024‑25 booster campaign.
Officials said a national press conference on 3 Sept 2026 will outline the logistics for rural health clinics, many of which struggled to secure doses last year.
Trump Administration's Shifting Guidance Fuels Public Uncertainty
President Donald Trump's office has issued three separate statements since June regarding the timing of flu and Covid vaccinations, each contradicting the previous one.
The latest memo, released on 1 Sept 2026, advises Americans to "wait for the next official guidance" before booking any shots, a stance at odds with the joint recommendations from the AAP, AAFP, ACOG and IDSA.
Sources confirmed that the White House's health‑policy team is still negotiating with the CDC over the definition of "high‑risk" groups, a debate that has delayed public‑service announcements.
- Trump's June tweet suggested flu shots could be postponed until after Thanksgiving • July statement warned of "potential side‑effects" from the new Covid booster • Sept 1 memo urges "patience" before acting
The mixed messages have already shown measurable impact: a Kaiser Family Foundation poll released on 31 Aug 2026 found that 38 % of respondents were unsure whether to get the flu shot, up from 24 % in May.
Officials said the administration plans to hold a briefing on 5 Sept 2026 to align its position with the CDC's latest advisory, but critics warn that the delay may cost lives as the flu season approaches.
"Clear, consistent messaging is the single most important factor in vaccine uptake," said a senior health‑policy analyst at the Brookings Institution, without naming the individual.